816 filings
F-1
KZIA
Kazia Therapeutics Limited
29 May 24
Registration statement (foreign)
8:55am
424B3
KZIA
Kazia Therapeutics Limited
23 May 24
Prospectus supplement
7:03am
6-K
KZIA
Kazia Therapeutics Limited
23 May 24
Current report (foreign)
7:00am
424B3
KZIA
Kazia Therapeutics Limited
17 May 24
Prospectus supplement
4:07pm
6-K
KZIA
Kazia Therapeutics Limited
17 May 24
Current report (foreign)
4:05pm
424B3
ezrv if9weihxyvs7e
1 May 24
Prospectus supplement
4:06pm
6-K
ms65mrshe9xka opc8u0
1 May 24
Kazia Reports Successful Stage 1 Completion of the EVT801
4:01pm
424B3
09bqbjwtvvuwgp9bg9
19 Apr 24
Prospectus supplement
4:30pm
6-K
5rnu81495 dt6qo0bi
19 Apr 24
Current report (foreign)
4:26pm
424B3
9npnfnzy3su
27 Mar 24
Prospectus supplement
8:37am
6-K
5dt8yhn ef4luuv0i
27 Mar 24
Current report (foreign)
8:26am
6-K
527bwu de2g
26 Mar 24
Current report (foreign)
8:02am
424B3
djk3vo2l4r 2rcssu
21 Feb 24
Prospectus supplement
4:19pm
6-K
xopbwko8jsi00ro2a
21 Feb 24
Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint
9:19am
EFFECT
ny9s3903
6 Feb 24
Notice of effectiveness
12:15am
424B3
0cojp mk85bwil
5 Feb 24
Prospectus supplement
4:19pm
CORRESP
qcoe ydxli
2 Feb 24
Correspondence with SEC
12:00am
UPLOAD
3qvgvi
1 Feb 24
Letter from SEC
12:00am
F-1
tytgy2ini nygonr0j
31 Jan 24
Registration statement (foreign)
12:00am
6-K
1rvgdbdxlimr
18 Jan 24
Current report (foreign)
4:30pm